| 1 |
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review |
|
| | Yet H. Khor, Yvonne Ng, Hayley Barnes, Nicole S.L. Goh, Christine F. McDonald, Anne E. Holland | | | European Respiratory Review. 2020; 29(157): 190158 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
A preliminary study: MUC5B promoter polymorphism and its association with IPF |
|
| | Hoda Ali Abu Yusuf, Mohamed Galal, Safy Kaddah, Marwa el Sharkawy, Mohamed Shaaban Mousa, Heba Moussa | | | The Egyptian Journal of Bronchology. 2020; 14(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Diabetes Mellitus Contributes to Idiopathic Pulmonary Fibrosis: A Review From Clinical Appearance to Possible Pathogenesis |
|
| | Dongguang Wang, Yao Ma, Xiang Tong, Yonggang Zhang, Hong Fan | | | Frontiers in Public Health. 2020; 8 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Comorbid Metabolic Disorders in Chronic Lung Diseases |
|
| | M.I. Gumeniuk | | | Infusion & Chemotherapy. 2019; (3): 5 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Lifestyle associated diseases and risk of pulmonary hypertension in patients with idiopathic pulmonary fibrosis |
|
| | Safy Kaddah,Sabah Ahmed | | | Egyptian Journal of Chest Diseases and Tuberculosis. 2016; 65(1): 127 | | | [Pubmed] [Google Scholar] [DOI] | |
|
